NDC codes

FDA NDC Directory
Product NDC (as listed)66220-637Labeler and product segments. Claims need a package NDC.
Product NDC at billing width66220-0637Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
66220-637-316622006373166220063731168 h in 1 POUCH (66220-637-31)Marketed from Jul 16, 2024
66220-637-726622006377266220063772168 h in 1 POUCH (66220-637-72)Marketed from Jul 16, 2024 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Sancuso
Generic name (nonproprietary)
granisetron
Active ingredients
Granisetron — 3.1 mg/24h
Dosage form
Patch
Route
Transdermal
Labeler
Cumberland Pharmaceuticals Inc.NDC labeler code 66220
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 022198
Marketing start
Listing expires
Other FDA classes
Serotonin 3 Receptor Antagonists (Mechanism)
Identifiers
Product ID 66220-637_c78db5de-683f-41bd-8f25-700b9d0e2e46SPL ID c78db5de-683f-41bd-8f25-700b9d0e2e46SPL set ID 7379369a-03df-4ec3-8f2e-66645cc736d8RxCUI 825003, 825005UNII WZG3J2MCOLUPC 0066220637310

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466220063731 followed by a unit qualifier and the quantity

Package 66220-0637-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

SANCUSO ® is indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration. SANCUSO is a serotonin-3 (5-HT 3 ) receptor antagonist indicated for the prevention of nausea and vomiting in adults receiving moderately and/or highly emetogenic chemotherapy for up to 5 consecutive days. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 66220-637

What is NDC 66220-637?
66220-637 is the product NDC for Sancuso (granisetron), Granisetron 3.1 mg/24h patch, listed with the FDA by Cumberland Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Sancuso (Granisetron).
What is the active ingredient?
Granisetron.
Who is the labeler?
Cumberland Pharmaceuticals Inc., NDC labeler code 66220. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sancuso?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in